Friday, 10 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > FTC And Congress Ramp Up Efforts To Rein In Drug Patent Evergreening
Health and Wellness

FTC And Congress Ramp Up Efforts To Rein In Drug Patent Evergreening

Last updated: October 8, 2024 6:16 pm
Share
FTC And Congress Ramp Up Efforts To Rein In Drug Patent Evergreening
SHARE

The United States is facing a significant challenge when it comes to drug patent evergreening, a practice that extends patent rights on specific products to block generic and biosimilar competition. This issue has caught the attention of both the Federal Trade Commission (FTC) and Congress, who are now taking steps to address it.

The American patent system for pharmaceuticals is designed to incentivize innovation by allowing drug companies to sell new medications exclusively for a period of time before generics or biosimilars can enter the market. However, companies have found ways to extend their patent protection by filing secondary patents that cover aspects like dosages, formulations, and delivery mechanisms. This practice can grant them an additional three years of monopoly protection, leading to higher drug prices for consumers.

Recent studies have shown a significant increase in the number of patents filed by drug companies, many of which involve minor changes to existing drugs. While some of these changes can benefit patients, such as improving adherence and persistence, others are seen as abuses of the patent system. For example, companies have been known to file patents for insignificant items like a plastic strap attached to an inhaler, which has no direct impact on the drug itself.

The issue extends beyond inhalers, with nearly three-quarters of new drug patents issued between 2005 and 2015 being for pharmaceuticals already on the market. This practice has raised concerns about the hindrance of competition and the resulting impact on healthcare spending.

One area of particular focus for the FTC is biosimilars, which have the potential to significantly reduce healthcare costs. However, patent thickets, which create hurdles for generic and biosimilar competitors, have impeded their uptake. Bipartisan efforts are underway in Congress to address these issues, with multiple bills aimed at closing loopholes in the patent system.

See also  Declining Trump Met With Congress And Didn't Know What Was In BBB

Experts and policymakers are advocating for reforms that strike a balance between rewarding innovation and promoting competition to make prescription drugs more affordable. The Affordable Prescriptions for Patients Act, for example, seeks to limit patent thickets and product hopping, giving the FTC authority to enforce limits on patent litigation.

While the pharmaceutical industry defends its intellectual property rights, there is growing consensus that patent reform is necessary. The FTC has taken steps to challenge drug makers on improperly listed patents, but the effectiveness of these actions remains to be seen.

In conclusion, pressure is mounting for changes to the pharmaceutical patent system, and it remains to be seen how quickly these reforms will be implemented. With bipartisan support and regulatory scrutiny, the hope is that these efforts will lead to a more competitive and affordable drug market for consumers.

TAGGED:CongressDrugEffortsEvergreeningFTCpatentrampRein
Share This Article
Twitter Email Copy Link Print
Previous Article Why Josh Sargent is the USMNT striker Mauricio Pochettino wants to form a partnership with Christian Pulisic Why Josh Sargent is the USMNT striker Mauricio Pochettino wants to form a partnership with Christian Pulisic
Next Article An Art Dealer Bought This Painting at a Barn Sale for . It Turned Out to Be an Emily Carr Worth Nearly 0,000 An Art Dealer Bought This Painting at a Barn Sale for $50. It Turned Out to Be an Emily Carr Worth Nearly $150,000
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Inter Miami look like the old PSG or last few Barcelona teams with Lionel Messi, and that’s not a good thing

Paris Saint-Germain demonstrated their dominance against Inter Miami in a recent match, showcasing their superior…

June 29, 2025

Democrat congressman Suhas Subramanyam dragged for ‘weird’ TikTok ‘aura farming’ trend video

Rep. Suhas Subramanyam, D-Va., recently joined the trend of "aura farming" on TikTok by sharing…

July 17, 2025

Nancy Pelosi Spits Bile at Trump After He Bombs Iranian Nuclear Sites – But Forgets What She Said When Obama Was Bombing Libya |

The Inevitable Political Backlash As anticipated, the political landscape has erupted following the United States…

June 22, 2025

Why Today’s Leaders Must Prioritize Mental Health—Theirs And Yours

In the United States, stress-related absenteeism due to loneliness costs companies an estimated $154 billion…

May 19, 2025

That weird call or text from a senator is probably an AI scam

In a recent alert issued by the FBI, a new scam involving text messages and…

May 16, 2025

You Might Also Like

President Trump is in ‘exceptional health,’ his doctor says, after visit to Walter Reed
Health and Wellness

President Trump is in ‘exceptional health,’ his doctor says, after visit to Walter Reed

October 10, 2025
A race to Congress: The strategies Tenn. primary winners Matt Van Epps and Aftyn Behn are banking on
Lifestyle

A race to Congress: The strategies Tenn. primary winners Matt Van Epps and Aftyn Behn are banking on

October 10, 2025
STAT+: HHS employees to be fired as White House enacts mass terminations it blames on shutdown
Health and Wellness

STAT+: HHS employees to be fired as White House enacts mass terminations it blames on shutdown

October 10, 2025
No, circumcision doesn’t cause autism
Health and Wellness

No, circumcision doesn’t cause autism

October 10, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?